Letrozole 1 mg Astera Labs
€13.00
General introduction and principle of operation Letrozole 1 mg Astera Labs
Letrozole 1 mg Astera Labs is a potent aromatase inhibitor primarily used in the treatment of hormone receptor-positive breast cancer in postmenopausal women. The active compound, letrozole, works by inhibiting the aromatase enzyme, which plays a crucial role in synthesizing estrogen. By reducing estrogen levels in the body, letrozole effectively deprives estrogen-sensitive tumors of their growth stimulus, thereby hindering tumor progression and recurrence. This mechanism not only supports cancer treatment but also assists in managing estrogen-related conditions in various contexts, including sports and bodybuilding.
Main components and active substances
Letrozole 1 mg Astera Labs contains the active ingredient letrozole, classified as an aromatase inhibitor. Additionally, this pharmaceutical formulation includes excipients that facilitate the pill’s stability and effectiveness. Understanding the active components and their respective roles enhances the treatment experience.
- Letrozole: This is the primary active substance that inhibits estrogen synthesis.
- Excipients: Various inactive substances that enhance the drug’s stability and absorption rate.
- Hydroxyl Propyl Methylcellulose: A binder that helps maintain the pill’s structure.
- Lactose Monohydrate: An inactive ingredient used to improve the consistency of the pills.
Mechanisms of action and expected results
Letrozole’s mode of action involves the selective inhibition of the aromatase enzyme, which converts androgenic steroids into estrogens. As a result, the overall estrogen production in the body significantly decreases. This action leads to several anticipated benefits, particularly in the context of cancer therapy and athletic performance enhancement.
- Reduced Estrogen Levels: Lower estrogen helps in controlling tumor growth in hormone-sensitive cancers.
- Increased Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH): These hormones may rise, promoting testosterone production.
- Impact on Body Composition: Users may experience a favorable reduction in fat mass while preserving lean muscle tissue.
Recommendations for use
It is critical to use Letrozole 1 mg Astera Labs under appropriate medical guidance. The dosing regime depends on the indication, whether for cancer treatment or bodybuilding. Adhering to prescribed dosage and monitoring is essential for achieving the desired benefits while minimizing side effects.
- Medical Dosage: Typically, 2.5 mg daily for breast cancer treatment, prescribed by an oncologist.
- Sports Usage: Dosages generally range from 0.5 mg to 2.5 mg daily, adjusted based on individual needs and cycles.
- Monitoring: Regular lab tests for liver function, lipid profiles, and bone density are vital during long-term use.
Possible risks and contraindications Letrozole 1 mg Astera Labs
While Letrozole 1 mg Astera Labs is effective, it may carry certain risks and contraindications. Individuals should be informed about these aspects to ensure safe usage.
- Side Effects: Common side effects include hot flashes, joint pain, and fatigue.
- Osteoporosis Risk: Prolonged use may increase the risk of fractures due to decreased bone density.
- Cardiovascular Concerns: It may cause a decrease in blood pressure, requiring caution in those with existing heart conditions.
| Active substance | Letrozole |
|---|---|
| Water Retention | Reduces water retention |
| Hepatotoxicity | Low hepatotoxicity |
| Lab Test | Monitoring of liver function tests, lipid profiles, and bone density |
| Also known as | Letrozol |
| Blood pressure | Can cause a decrease in blood pressure |
| Trade name | Femara |
| Storage conditions | Store at room temperature away from moisture and heat |
| Chemical name | 4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile |
| Formula | C17H11N5 |
| Substance class | Aromatase inhibitor |
| Main action | Inhibits the enzyme aromatase, preventing the synthesis of estrogen |
| Half-life | 2 days |
| Dosage (medical) | 2.5 mg daily |
| Dosage (sports) | Typically 0.5 mg to 2.5 mg daily depending on purpose and cycling needs |
| Effects | Reduces estrogen levels, increases luteinizing hormone and follicle-stimulating hormone levels |
| Side effects | Hot flashes, joint pain, fatigue, increased risk of osteoporosis, nausea |
| Use in sports | Used by bodybuilders and athletes to reduce estrogen levels and increase testosterone levels |
| Active ingredient, mg | 1 |
| Release form | Pills |
| Manufacturer | ASTERA LABS |
| Packing | Pack (50 pills) |
| 5 |
|
0 |
| 4 |
|
0 |
| 3 |
|
0 |
| 2 |
|
0 |
| 1 |
|
0 |



Reviews
There are no reviews yet.